Alpha Cubed Investments LLC Increases Stake in Intuitive Surgical, Inc. $ISRG

Alpha Cubed Investments LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,600 shares of the medical equipment provider’s stock after purchasing an additional 10,677 shares during the period. Intuitive Surgical comprises about 1.4% of Alpha Cubed Investments LLC’s portfolio, making the stock its 19th biggest holding. Alpha Cubed Investments LLC’s holdings in Intuitive Surgical were worth $41,413,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Tobam boosted its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Riggs Asset Managment Co. Inc. lifted its position in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its stake in Intuitive Surgical by 3,750.0% in the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 75 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ISRG. Raymond James Financial raised their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Evercore ISI dropped their price target on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Finally, Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands the da Vinci 5 indication set into select advanced cardiac procedures — large addressable‑market implication and a long‑term revenue tail for systems and consumables. Read More.
• Positive Sentiment: TD Cowen initiated/raised coverage to a strong‑buy, which can attract institutional demand and support near‑term buying interest. Read More.
• Positive Sentiment: Major sell‑side support continues (Barclays reaffirmed buy) and HSBC issued a bullish price‑appreciation forecast — both reinforce positive analyst momentum around growth prospects. Read More. Read More.
• Positive Sentiment: Active managers (Polen Capital) are highlighting ISRG as a core growth holding, signaling conviction from long‑term growth investors. Read More.
• Neutral Sentiment: Analysts are split on valuation — some price‑target trims (e.g., Evercore ISI) coexist with higher targets from other firms; that creates mixed guidance for short‑term price direction. Read More.
• Neutral Sentiment: Coverage pieces questioning whether to “reassess” ISRG after recent share weakness may drive flows from momentum or value‑oriented investors, but they’re not direct catalysts. Read More.
• Negative Sentiment: Significant insider selling by director Gary S. Guthart (24,500 shares + 2,800 shares disclosed) — large, disclosed sales can trigger profit‑taking and amplify downward pressure on the stock near term. Read More.
• Negative Sentiment: EVP Myriam Curet sold 230 shares (smaller amount) — adds to the day’s insider activity and can increase negative sentiment despite being immaterial in size. Read More.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Craig H. Barratt sold 750 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 75,557 shares of company stock worth $42,000,903. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Down 2.8%

NASDAQ:ISRG opened at $507.55 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The company has a fifty day simple moving average of $559.78 and a two-hundred day simple moving average of $511.72. The company has a market cap of $181.95 billion, a price-to-earnings ratio of 64.33, a price-to-earnings-growth ratio of 4.05 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the company posted $2.21 earnings per share. The business’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.